76
Views
0
CrossRef citations to date
0
Altmetric
Original Article

References

Pages 162-176 | Published online: 04 Jan 2010

  • Adams D. D. The presence of an abnormal thyroid-stimulating hormone in the serum of some thyrotoxic patients. J. clin. Endocrin 1958; 18: 699, (27)
  • Adams B. G., Davies B. M. Neurological changes associated with P.A.S. and I.N.A.H. therapy. J. ment. Sci 1961; 107: 943, (126)
  • Alexander N. M. Iodide peroxidase in rat thyroid and salivary glands and its inhibition by antithyroid compounds. Fed. Proc 1959; 18: 179, (20)
  • Alexander N. M. Iodide peroxidase in rat thyroid and salivary glands and its inhibition by antithyroid compounds. J. biol. Chem. 1959; 234: 1530, (20)
  • Alexander N. M. A spectrophotometric assay for iodide oxidation by thyroid peroxidase. Analyt. Biochem. 1962; 4: 341, (20, 47)
  • Anbar M., Guttmann S., Lewitus Z. The mode of action of perchlorate ions on the iodine uptake of the thyroid gland. Int. J. appl. Radiat. 1959; 7: 87, (19)
  • Andersen H. Studies of hypothyroidism in children. (Diss.). Acta paediat. (Uppsala) 1960, Suppl. 125, (30)
  • Mayer R. W., Angel S. W., Morton M. E. The direct antithyroid action of para-amino-salicylic acid and isoniazid. Amer. Rev. Tuberc. 1955; 71: 889, (41, 45)
  • Ann. N. Y. Acad. Sci. Modern Concepts of Thyroid Physiology 1960; 86: 311, (Edit.: Whitelock, O. v. St.). (12)
  • Arnott D. G., Doniach I. The effect of compounds allied to resorcinol upon the uptake of radioactive iodine (131 I) by the thyroid of the rat. Biochem. J. 1952; 50: 473, (47)
  • Astwood E. B. The chemical nature of compounds which inhibit the function of the thyroid gland. J. Pharmacol. exp. Ther. 1943; 78: 79, (47)
  • Astwood E. B., Bissell A., Hughes A. M. Further studies on the chemical nature of compounds which inhibit the function of the thyroid gland. Endocrinology 1945; 37: 456, (33, 47)
  • Astwood E. B., Stanley M. M. Use of radioactive iodine in the study of thyroid function in man. West. J. Surg. 1947; 55: 625, (37)
  • Astwood E. B., Greer M. A., Ettlinger M. G. 1–5-vinyl-2-thiooxazolidone, an antithyroid compound from yellow turnip and from brassica seeds. J. biol. Chem. 1949; 181: 121, (27)
  • Astwood E. B. Mechanism of action of antithyroid compounds. Brookhaven Symposia in Biology VII, Upton, NY, 1955; 61, (47)
  • Balint J. A., Fraser R., Hanno M. G. W. Radioiodine measurements of thyroid function during and after P.A.S. treatment of tuberculosis. Brit. med. J. 1954; I: 1234, (32, 37, 41, 47, 81)
  • Bang H. O., Jacobsen L. Kramer, Strandgaard E., Yde H. Metabolism of isoniazid and para-aminosalicylic acid (PAS) in the organism and its therapeutic significance. Acta tuberc. scand. 1962; 41: 237, (81)
  • Barker M. H. The blood cyanates in the treatment of hypertension. J. Amer. med. Ass. 1936; 106: 762, (26)
  • Barker S. B., Humprey M. J., Soley M. H. The clinical determination of protein-bound iodine. J. clin. Invest. 1951; 30: 55, (57)
  • Barker S. B. Chemical assay of thyroxine-like materials. Methods in hormone research, R. I. Dorfman, , NY-Lond. 1962; vol. 1: 351, (91)
  • Bastenie P. S., Ermans M. A., Thys O., Beckers C, van den Schrieck H. G., de Visscher M. J. clin. Endocrin. 1962; 22: 187, (17, 66)
  • Bastenie P. A., de Visscher M., et coll., Ermans M. A., et coll., Battezzati M. L'azione regolarizzante dell'acido para-amino-salicilico sul metabolismo basale nel morbo di Basedow. Inform. med. (Genova) 1950; 4: 347, (44)
  • Baumann E. Ueber das normale Vorkommen von Jod im Thierkörper. Hoppe-Seylers Z. physiol. Chem. 1895; 21: 319, (14)
  • Baumann E. Ueber das normale Vorkommen des Jods im Thierkörper. (III. Mittheilung). Hoppe-Seylers Z. physiol. Chem. 1896; 22: 1, (14)
  • Baumann E., Roos E. Ueber das normale Vorkommen des Jods im Thierkörper. (II. Mittheilung). Hoppe-Seylers Z. physiol. Chem. 1896; 21: 481, (14)
  • Baumann E. J., Metzger N. Behavior of the thyroid toward elements of the seventh periodic group. Proc. Soc. exp. Biol. (N.Y.) 1949; 70: 536, (18)
  • Baumann E. J., Searle N. Z., Yalow A. A., Siegel E., Seidlin S. M. Behavior of thyroid toward elements of seventh periodic group. Fed. Proc. 1952; 11: 184, (18)
  • Bavin E. M., James B. Pharmacology of para-aminosalicylic acid. J. Pharm. Pharmacol. 1952; 4: 856, (42)
  • Beale D., Whitehead J. K. A preliminary investigation of the levels of 3-monoiodotyrosine and 3,5-diiodotyrosine in human blood plasma using double isotope dilution technique. Clin. chim. Acta 1960; 5: 150, (15)
  • Beattie J., Chambers R. D. The anti-thyroid action of para-amino-salicylic acid. J. Endocr. 1953; 10: 65, (42, 43, 46, 48, 82)
  • Beierwaltes W. H., Robbins J. Familial increase in the thyroxine-binding sites in serum alpha globulin. J. clin. Invest. 1959; 38: 1683, (23)
  • Beierwaltes W. H., Carr E. A., Hunter R. L. Hereditary increase in the thyroxine-binding sites in the serum alpha globulin. Trans. Ass. Amer. Phycns. 1961; 74: 170, (24)
  • Beisel W. R., Zainal H., Hane S., Diraimondo V. C., Forsham P. H. Low thyroidal iodine uptake with euthyroidism associated with deficient thyroid-binding globulin but normal Cortisol binding. J. clin. Endocrin. 1962; 22: 1165, (24)
  • Béraud Th., Scazziga B. R., Vannotti A. Formation in vivo de glucuroconjugués des hormones thyroïdiennes dans le foie du rat. Acta endocr. (Kbh.) 1956; 22: 55, (51)
  • Bergqvist N., de Maré O. Conteben-skada: hypothyreotisk struma, hjärnödem, mors. Nord. Med. 1951; 45: 474, (32, 33, 34, 41)
  • Bergqvist N., de Maré O. Till frågan om biverkningar vid para-aminosalicylsyre- och conteben-terapi. Svenska Läk.-Tidn. 1951; 48: 2841, (32, 33, 34)
  • Bergqvist N., de Maré O. Hypothyroidism and cerebral edema following combined treatment of tuberculosis with conteben (TB I 698) and p-amino-salicylic acid. Acta med. scand. 1952; 143: 323, (32, 33, 34)
  • Berman L. Human thyrotoxicosis: response to para-aminobenzoic acid. Proc. Soc. exp. Biol. (N. Y.) 1945; 59: 70, (48)
  • Berson S. A., Yalow R. S., Sorrentino J., Roswitt B. The determination of thyroidal and renal plasma I 131 clearance rates as a routine diagnostic test of thyroid dysfunction. J. clin. Invest. 1952; 31: 141, (59)
  • Berson S. A., Yalow R. S. The iodide trapping and binding functions of the thyroid. J. clin. Invest. 1955; 34: 186, (17)
  • Berson S. A. Pathways of iodine metabolism. Amer. J. Med. 1956; 20: 653, (16)
  • Besta B., de Simoni G., Moretti E. Modificazioni istologiche di ghiandole endocrine in animali da esperimento trattati con acido para-aminosalicilico (P.A.S.). Arch. Med. interna (Parma) 1953; 5: 103, (42)
  • Billion H., Kühne P. Der Wert verschiedener Radiojodtestverfahren für die Differential-diagnostik von Schilddrüsenfunktionsstörungen. Z. klin. Med. 1954; 152: 411, (67)
  • Birkhill F. R., Corrigan K. N., Hayden H. S. The metabolism of radioactive iodine (I 131) in patients with cardiac disease. Amer. J. Roentgenol. 1952; 67: 42, (51)
  • Blau N. F. The determination of thyroxine in the thyroid gland. J. biol. Chem. 1933; 102: 269, (69)
  • Blizzard R. M. Inherited defects of thyroid hormone synthesis and metabolism. Metabolism 1960; 9: 232, (18)
  • Block R. J., Mandl R. H., Keller S., Werner S. C. The binding of mixtures of iodoamino acids and of inorganic iodide by various serum proteins. Arch. Biochem. 1958; 75: 508, (15)
  • Block R. J., Werner S. C., Mandl R. H., Row V. V., Radichevich I. The probable presence of diiodotyrosine and of monoiodotyrosine in human serum. Arch. Biochem. 1960; 88: 98, (15)
  • Braasch J. W., Floch E. V., Albert A. A quantitative method for the separation of the iodinated amino acids of thyroid tissue. Endocrinology 1954; 55: 768, (15)
  • Braasch J. W., Albert A., Keating F. R., Black B. M. A note on the iodinated constituents of normal thyroids and of exophthalmic goiters. J. clin. Endocr. 1955; 15: 732, (15)
  • Brinkman G. L., Coates E. O., jr. The goitrogenic effect of para-aminosalicylic acid during the therapy of pulmonary tuberculosis. Amer. Rev. Tuberc. 1954; 69: 458, (31, 32, 33, 34)
  • Brucer M. Radioisotope Scanning (ORINS-20), I. ed. Washington 1958; 47, (54)
  • Brucer M. Thyroid radioiodine uptake measurement, 1. ed. Oak Ridge 1959, Tenn. (54)
  • Brun C. A rapid method for the determination of para-aminohippuric acid in kidney function tests. J. Lab. clin. Med. 1951; 37: 955, (95)
  • Bull G. M., Fraser R. Myxoedema from tesorcinol ointment applied to leg ulcers. Lancet 1950; 258: 851, (34)
  • Buttaro C. A. Sull'azione antitiroidea dell'acido para-aminosalicilico e dell'idrazide dell'acido isonicotinico. Rif. med. 1953; 68: 345, (33)
  • Canadell J. M. Exophthalmie et thyreostimuline. Rapports de la Ve reunion des endocrinologistes de la langue française. Masson et Cle, Paris 1959; 178, (29)
  • Carenza P., Ziliotto D., Girolami A., Casson P. La prova della captazione tiroidea dell'iodio radioattivo nella diagnostica funzionale delle tireopatie. Acta isotop 1962; 1: 293, (66)
  • Cassano C., Baschieri L., Andreani D. Recherches sur le métabolisme de l'iode dans les goitres et dans les syndromes hypersurrénaliens. Helv. med. Acta. 1957; 24: 216, (17, 114)
  • Cassano C., Baschieri L., Andreani D. Troubles extra-thyroidiens du a l'iode. Masson et Cle, Paris 1959; 85, (17, 114). Rapports de la Ve reunion des endocrinologistes de la langue française
  • Cassano C., Baschieri L., Andreani D. Étude de 48 cas de goitre simple. Advances in Thyroid Research, R. Pitt-Rivers, Lond 1961; 307, (17, 114)
  • Cattaneo C., De Simoni G., Moretti E. Il comportamento dello jodio sierico precipitabile (J.S.P.) in cavie trattate con chemioterapici ed antibiotici antitubercolari. Gazz. int. Med. Chir. 1956; 61: 2677, (42, 48)
  • Chaia J. A propos de quatre goitres après pas-therapie. J. med. liban. 1956; 9: 59, (32, 33, 35)
  • Chaia J. Les goitres thérapeutiques. Rev. méd. Moy. Or. 1956; 13: 241, (32, 33, 35)
  • Childs D. S., Keating F. R., jr, Rall J. E., Williams M. M. D., Power M. H. The effect of varying quantities of inorganic iodide (carrier) on the urinary excretion and thyroidal accumulation of radioiodine in exophthalmic goiter. J. clin. Invest. 1950; 29: 726, (17)
  • Choufoer J. C., Querido A. Aangeboren Stoornissen in de Produktie van Schildklierhormon. Folia med. neerl. 1959; 2: 186, (24)
  • Christensen L. K. A method for the determination of free, non-protein bound thyroxine in serum. Scand. J. clin. Lab. Invest. 1959; 11: 326, (86)
  • Christensen L. K. Thyroxine-releasing effect of salicylate and of 2,4-dinitrophenol. Nature (London). 1959; 183: 1189, (41, 42, 44, 86)
  • Christensen L. K. The metabolic effect of p-aminosalicylic acid. Acta endocr. (Kbh.). 1959; 31: 608, (41,42,44, 86)
  • Clark D. E., Moe R. H., Adams E. E. The rate of conversion of administered inorganic radioactive iodine into protein-bound iodine of plasma as an aid in the evaluation of thyroid function. Surgery 1949; 26: 331, (61)
  • Clarke K. H., Aujard R. L. Thyroid symposium III: The use of radioactive iodine I 131 in the diagnosis of hyperthyroidism: Physical aspects. Med. J. Aust. 1954; 1: 891, (67)
  • Clausen J., Munkner T. Thyroid hormone binding proteins in human serum characterized by immuno-electrophoresis and auto-radiographic tracings. Proc. Soc. exp. Biol. 1960; 104: 40, (23, 44, 85)
  • Clausen K. H., Kjerulf-Jensen K. Artificial myxoedema during para-aminosalicylic acid therapy. Nord. Med. 1951; 45: 475, (11, 32, 33, 34, 83)
  • Clayton G. W., Smith J. D., Leiser A. Familial goiter with defect in intrinsic metabolism of thyroxine without hypothyroidism. J. Pediat. 1958; 52: 129, (20)
  • Clements F. W. Naturally occuning goitrogens. Brit. med. Bull. 1960; 16: 133, (27)
  • Clode W., Sobral J. M., Baptista A. M. Bromine interference in iodine metabolism. Advances in thyroid research, R. Pitt-Riveis, Lond 1961; 65, (18)
  • Coindet J. F. Bibl. univers. Sci. Arts. 1820; 14: 190, Quoted from W.H.O. Monograph Series no. 44, Geneva 1960, p. 21. (14)
  • Corti L., Romualdi G. Modificazioni istopatologiche da tiosemicarbazone nella ghiandola tiroide. Folia Endocrinologica 1950; 3: 139, (33)
  • Cosson J. A propos d'un cas de goitre apparu pendant un traitement par l'acide para-aminosalicylique (Thèse). R. Vezin, Paris 1957, (33, 34)
  • Coulaud E. Apparition de goitres chez des tuberculeuses traitées et guéries par le P.A.S. Action du P.A.S. sur le corps thyroïde du rat. Rev. Tuberc. (Paris). 1954; 18: 261, (32, 33)
  • Coulaud E. Action de P.A.S., de l'isoniazide et de substances voisines sur le corps thyroïde du rat. Rev. Tuberc. (Paris). 1955; 19: 583, (42, 43)
  • Covello M., Capone A. Determinazione quantitativa dell' acido 4-amino-5-iodosaIicilico (JPAS) nel sangue e nelle urine. Ann. Chim. (Roma). 1951; 41: 367, (93)
  • Danowski T. S. Thyroid. Clinical Endocrinology, 1. ed. The Williams & Wilkins Co. 1962; vol. 2, (12, 29)
  • Davies H. T., Galbraith H. J. B. Goitre and hypothyroidism developing during treatment with P.A.S. Brit. med. J. 1953; I: 1261, (33, 34)
  • Davies T. W., Morgan D. B., Thomas J. H. Thyroid enlargement during P.A.S. therapy. Brit. J. Tuberc. 1953; 47: 233, (33)
  • De Groot L. J., Postel S., Litvak J., Stanbury J. B. Peptide-linked iodotyrosines and iodothyronines in the blood of a patient with congenital goiter. J. clin. Endocr. 1958; 18: 158, (69)
  • De Groot L. J., Stanbury J. B. The syndrome of congenital goiter with butanol-insoluble serum iodine. Amer. J. Med. 1959; 27: 586, (69)
  • Dempsey E. W. Fluorescent and histochemical reactions in the rat thyroid gland at different states of physiological activity. Endocrinology 1944; 34: 27, (47)
  • Der Kinderen P. J., Schwarz F., Houtstra-Lanz M. Exophthalmos-producing substance in human serum. J. clin. Endocr. 1960; 20: 712, (29)
  • De Robertis E. Proteolytic enzyme activity of colloid extracted from single follicles of the rat thyroid. Anat. Rec. 1941; 80: 219, (21)
  • De Robertis E., Grasso H. Peroxidase activity of the thyroid gland under normal and experimental conditions. Endocrinology 1946; 38: 137, (47)
  • De Visscher M. Fonctions thyroïdiennes et radioactivité du sang après administration de radioiode. Rec. Trav. chim. Pays-Bas. 1955; 74: 344, (67)
  • De Visscher M., Beckers C., van den Schrieck H.-G., de Smet M., Ermans A. M., Galperin H., Bastenie P. A. Endemic goiter in the Uele region (Republic of Congo). I. General aspects and functional studies. J. clin. Endocr. 1961; 21: 175, (66)
  • Dimitriadou A., Turner P. C. R., Slater J. D. H., Fraser R. Lodotyrosine-like material in serum detected by analysis for 127I but not 131I. Biochem. J. 1962; 82: 20, (15)
  • Dimitriadou A., Turner P. C. R., Fraser R. Activation analysis of paper chromatograms for iodine (127I-128I). Nature. (London) 1963; 197: 446, (15)
  • Dobyns B. M., Wright A., Wilson L. Assay of the exophthalmos-producing substance in the serum of patients with progressive exophthalmos. J. Clin. Endocr. 1961; 21: 648, (29)
  • Doniach I., Logothetopoulos J. The goitrogenic action of resorcinol in rats. Brit. J. exp. Path. 1953; 34: 146, (34)
  • Edwards D. A. W., Rowlands E. N., Trotter W. R. The mechanism of the goitrogenic action of p-aminosalicylic acid. Lancet 1954a; 267: 1051, (35, 36, 39, 82, 124)
  • Eichhorn O. Die Problematik der Schilddrüsenfunktionsprüfungen mit Radiojod in Jodmangelgebieten. Schweiz. med. Wschr. 1955; 85: 879, (66)
  • Ermans A. M., Bastenie P. A., Galperin H., Beckers C., van den Schrieck H.-G., de Visscher M. Endemic goiter in the Uele region. II. Synthesis and secretion of thyroid hormones. J. clin. Endocr. 1961; 21: 996, (66)
  • Escobar del Rey F., Morreale de Escobar G. The effect of propylthiouracil, methylthiouracil and thiouracil on the peripheral metabolism of 1-thyroxine in thyroidectomized, 1-thyroxine maintained rats. Endocrinology 1961; 69: 456, (26)
  • Espersen E. Goitre and myxoedema during treatment of pulmonary tuberculosis with paraaminosalicylic acid. Acta tuberc. scand. 1958; 36: 110, (31, 33, 34, 83)
  • Espersen E. Nord. Med. 1960; 64: 1399, (31, 33, 34, 83)
  • Evans J. An unusual type of reaction to P.A.S. with a review of its toxic effects. Brit. J. Tuberc. 1953; 47: 78, (31)
  • Fawcett D. M., Kirkwood S. The mechanism of the antithyroid action of iodide ion and of the “aromatic” thyroid inhibitors. J. biol. Chem. 1953; 204: 787, (26, 115)
  • Federman D., Robbins J., Rall J. E. Some observations on cretinism and its treatment. New Engl. J. Med. 1958; 259: 610, (18)
  • Fest T., Keleman A., Fest G., Almashi S. The influence of p-aminosalicylic acid administration on the course of experimental goitre (in Russian). Rev. Sci. méd. (Buc.) 1960; 5: 145, (42)
  • Field J. B., Pastan I., Johnson P., Herring B. Stimulation in vitro of pathways of glucose oxidation in thyroid by thyroid-stimulating hormone. J. biol. Chem. 1960; 235: 1863, (27, 36)
  • Field J. B., Johnson P., Kendig E., Pastan I. Further studies on effects of thyroid-stimulating hormone on thyroid glucose oxidation. J. biol. Chem. 1963; 238: 1189, (27, 36)
  • Fink K., Fink R. M. The formation of monoiodotyrosine from radioiodine in the thyroid of rat and man. Science 1948; 108: 358, (14)
  • Fischer D. B. Personal communication. 1962, (44)
  • Florsheim W. H., Dowling J. T., Meister L., Bodfish R. E. Familial elevation of serum thyroxine-binding capacity. J. clin. Endocr. 1962; 22: 735, (24)
  • Franklin A. L., Chaikoff I. L., Lerner S. R. The influence of goitrogenic substances on the conversion in vitro of inorganic iodide to thyroxine and diiodotyrosine by thyroid tissue with radioactive iodine as indicator. J. biol. Chem. 1944; 153: 151, (48)
  • Fraser R., Hobson Q. J. G., Arnott D. G., Emery E. W. The urinary excretion of radioiodine as a clinical test of thyroid function. Quart. J. Med. (n.s.). 1953; 22: 99, (38)
  • Fraser R. The diagnostic use of radioiodine in thyroid disease. Postgrad. Med. 1960; 36: 418, (67)
  • Freedberg A. S., Ureles A., Hertz S. Serum level of protein bound radioactive iodine (I 131) in the diagnosis of hyperthyroidism. Proc. Soc. exp. Biol. (N.Y.). 1949; 70: 679, (67)
  • Freedberg A. S., Chamowitz D. L., Kurland G. S. Thyroid function in normal and pathological states as revealed by radioactive iodine studies. Metabolism 1952; 1: 26, (51)
  • Freinkel N., Ingbar S. H. The relationship between metabolic activity and iodide-concentrating capacity of surviving thyroid slices. J. clin. Endocr. 1955; 15: 442, (17)
  • Freinkel N., Ingbar S. H. Effect of metabolic inhibitors upon iodide transport in sheep thyroid slices. J. clin. Endocr. 1955; 15: 598, (17)
  • Friis T. Protein-bound iodine in serum in thyrotoxicosis and myxoedema. Acta med. scand. 1954; 149: 463, (68)
  • Friis T. Thyroxine metabolism in man estimated by means of I 131-labelled 1-thyroxine. Acta endocr. (Kbh.). 1958; 29: 587, (16)
  • Friis T. Nord. Med. 1962; 66: 1736, (68)
  • Friis T., Christensen L. K. The diagnostic use of radioactive iodine in thyroid disorders. Dan. med. Bull. 1959; 6: 1, (52, 63, 64, 65, 67, 68)
  • Galton V., Pitt-Rivers R. A quantitative method for the separation of thyroid hormones and related compounds from serum and tissues with an anion-exchange resin. Biochem. J. 1959; 72: 310, (88, 90, 99)
  • Gedda P. O. On the effect of thyrotropic hormone on thyroid in the guinea-pig. (Diss.). Acta endocr. (Kbh.) 1960, Suppl. 56, (27)
  • Gold E. Iodide-induced goiter. Surgery 1959; 45: 424, (26)
  • Goodwin J. F., Miller H., Wayne E. J. A comparison of the anti-thyroid activity of para-aminobenzoic acid and thiouracil compounds. Lancet 1949; 257: 1211, (48)II
  • Goodwin J. F., Macgregor G., Miller H., Wayne E. J. The use of radioactive iodine in the assessment of thyroid function. Quart. J. Med. (n.s.). 1951; 20: 353, (67)
  • Greer M. A., Smith G. E. Method for increasing the accuracy of the radioiodine uptake as a test for thyroid function by the use of desiccated thyroid. J. clin. Endocr. 1954; 14: 1374, (45)
  • Groos J., Pitt-Rivers R. The identification of 3:5:3′-l-triiodothyronine in human plasma. Lancet 1952; 262: 439, (14)
  • Hald A. Statistiske Metoder, 1. ed. København 1948; 240, (55)
  • Halmi N. S., Spirtos B. N., Bogdanove E. M., Lipner H. J. A study of various influences on the iodide concentrating mechanism of the rat thyroid. Endocrinology 1953; 52: 19, (26)
  • Halmi N. S., Pitt-Rivers R. The iodide pools of the rat thyroid. Endocrinology 1962; 70: 660, (20)
  • Hamilton J. G., Soley M. H. Studies in iodine metabolism by the use of a new radioactive isotope of iodine. Amer. J. Physiol. 1939; 127: 557, (49)
  • Hamilton J. G., Soley M. H. Studies in iodine metabolism of the thyroid gland in situ by the use of radio-iodine in normal subjects and in patients with various types of goiter. Amer. J. Physiol. 1940; 131: 135, (49)
  • Hamilton J. G., Asling C. W., Garrison W. M., Scott K. G. The accumulation, metabolism and biological effects of astatine in rats and monkeys. Univ. Calif. Publ. Pharmacol. 1953; 2: 283, (18)
  • Hamilton R. R. Effect of P.A.S. on the thyroid gland. Brit. med. J. 1953; 4800: 29, (32, 33). Hammer, G.: Personal communication (1961). (128)
  • Hamolsky M. W., Stein M., Freedberg A. S. The thyroid hormone-plasma protein complex in man. II. A new in vitro method for study of “uptake” of labelled hormonal components by human erythrocytes. J. clin. Endocr. 1957; 17: 33, (23, 44)
  • Hanngren A. Determination of the antithyroid action of para-aminosalicylic acid using radioactive iodine. Lancet 1952; 263: 117, (36, 37, 82)
  • Hanngren Å. Nord. Med. 1953; 49: 302, (36)
  • Hanngren Å. Studies on the distribution and fate of C 14- and T-labelled p-aminosalicylic acid (PAS) in the body. (Diss.). Acta radiol. (Stockh.) 1959, Suppl. 175, (41, 42, 44, 94, 104)
  • Harington C. R., Randall S. S. Observations on the iodine-containing compounds of the thyroid gland. Isolation of dl-3:5-diiodotyrosine. Biochem. J. 1929; 23: 373, (15)
  • Hart F. D., Maclagan N. F. Myxoedema from resorcinol ointment. Lancet 1951; 260: 530, (34)
  • Hartmann N. Über den Abbau von Dijodtyrosin im Gewebe. Hoppe-Seylers Z. physiol. Chem. 1950; 285: 1, (22)
  • Heftman E. Chromatography, 1. ed. New York 1961, (87)
  • Heilesen B. Diffuse goitre induced by PAS. Acta tuberc. scand. 1960; 38: 325, Nord. Med. 64 (1960), 1387. (36,41, 128)
  • Henriques U. Personal communication. 1963, (126)
  • Hertz S., Roberts A., Evans R. D. Radioactive iodine as an indicator in the study of thyroid physiology. Proc. Soc. exp. Biol. 1938; 38: 510, (49)
  • Hetzel B. S., Good B. F., Wellby M. L., Charnock J. S. Salicylate-induced fall in plasma protein-bound iodine in hyperthyroidism. Lancet 1960; I: 957, (44)
  • Hetzel B. S., Good B. F., Wellby M. L., Charnock J. S. The effect of salicylate on plasma protein-bound iodine. Advances in Thyroid Research, R. Pitt-Rivers, Lond 1961; 56, (44)
  • Hickey F. C., Brownell G. L. Dynamic analysis of iodine metabolism in 4 normal subjects. J. clin. Endocr. 1954; 14: 1423, (16, 59)
  • Higgins G. M., Larson G. A. Hyperplasia of the thyroid gland induced by 4,2′-diaminophenyl-5′-thiazolesulfone (promizole). Proc. Mayo Clin. 1944; 19: 137, (33)
  • Higgins G. M. A study of the goitrogen promizole, with reference to the thyroid, metabolism and the blood. Amer. J. med. Sci. 1945; 210: 347, (33)
  • Hillmann G. Biosynthese und Stoffwechselwirkungen der Schilddrüsenhormone, 1. Aufl. Tübingen 1961, (12)
  • Hlad C. J., Bricker N. S. Renal function and I 131 clearance in hyperthyroidism and myxoedema. J. clin. Endocr. 1954; 14: 1539, (16, 59)
  • Hobson Q. J. G. Varicose ulceration of the legs and myxoedema and goitre following application of resorcinol ointment. Proc. roy. Soc. Med. 1951; 44: 164, (34)
  • Hoch F. L. Biochemical actions of thyroid hormones. Physiol. Rev. 1962; 42: 605, (12, 24)
  • Hoch F. L. Thyrotoxicosis as a disease of mitochondria. New Engl. J. Med. 1962; 266: 446–498, (12, 24)
  • Horn Z., Bogsch S. Chemical properties of P. A. S. Lancet 1950; II: 773, (42, 45)
  • Horst W. Klinische Radiojoddiagnostik der Schilddrüsenerkrankungen. Strahlenbiologie, Strahlentherapie, Nuklearmedizin und Krebsforschung, Ergebnisse 1952–1958, H. R. Schinz, H. Holthusen, H. Langendorff, B. Rajewsky, G. Schubert, Stuttgart 1959; 785, (66)
  • Hosoya T., Ui N. Demonstration and some properties of peroxidase in pig thyroid gland. Nature (Lond.). 1961; 192: 659, (47)
  • Hsia D. Y.-Y. Inborn Errors of Metabolism, 1. ed. Boston 1959, (13)
  • Hutchison J. H., Arneil C. C., McGirr E. M. Deficiency of an extra-thyroid enzyme in sporadic cretinism. Lancet 1957; II: 314, (24)
  • Hutchison J. H. Sporadic goitre and cretinism due to the production of an abnormal thyroid protein. Proc. roy. Soc. Med. 1961; 54: 533, (24)
  • Ingbar S. H., Freinkel N. Thyroid Hormones, H. N. Antoniades. Hormones in Human Plasma, Boston 1960, (23, 24)
  • Ingbar S. H., Freinkel N. Regulation of the peripheral metabolism of the thyroid hormones. Recent Progr. Hormone Res. 1960; 16: 353, (23, 24)
  • Ingbar S. H. Clinical and physiological observations in a patient with an idiopathic decrease in in the thyroxine-binding globulin of plasma. J. clin. Invest. 1961; 40: 2053, (24)
  • Ingbar S. H. Nature of the Circulating Thyroid Hormones. The Thyroid, 2. ed, S. C. Werner, , NY 1962; 26, (23)
  • Iversen K. Temporary Rise in the Frequency of Thyrotoxicosis in Denmark 1941–45. København 1948; 194, (28)
  • Jahn D., Kesmarszky E. Über Erfahrungen mit Conteben (Tb I/698). Neue med. Welt 1950; 1: 405, (33)
  • Jensen P. G. Comparison between scintillation counter and scintillation spectrometer for the measurement of I-131 uptake in the thyroid gland. Tracerlog 1957; 85: 1, (52, 53)
  • Jirousek L. Zur Frage des Brassica-Faktors und des endemischen Kropfes. Endokrinologie 1956; 33: 310, (27).Journal of Chromatography. : R1 values of iodide, iodotyrosines. Iodothyronines and their derivatives. 10 (1963). Chromatographic Data D 4–5. (91)
  • Kalant N., Intyre W. C. Thyroid function in nephrosis. Canad. med. Ass. J. 1957; 77: 979, (114)
  • Kalyuzhnyi I. T. État fonctionnel de la glande thyroïde chez les malades atteints de pleurosie exsudative d'etiologie tuberculeuse, avant et après le traitement avec PAS (en russe). Probl. Tuberk. 37 fasc. 1959; 3: 59, (36, 40, 82)
  • Kass I. Studies on the in vitro effects of radioactive I 131 labeled 3,5 diiodo PAS on the tubercle bacillus. Amer. Rev. Tuberc. 1952; 65: 316, (93)
  • Keating F. R., jr, Haines S. F., Power M. H., Williams M. M. D. The radioiodine-accumulating function of the human thyroid gland as a diagnostic test in clinical medicine. J. clin. Endocr. 1950; 10: 1425, (51)
  • Kendall E. C. The isolation in crystalline form of the compound containing iodin, which occurs in the thyroid. J. Amer. med. Ass. 1915; 64: 2042, (15)
  • Kjerulf-Jensen K., Wolffbrandt G. Antithyroid effect of p-amino-salicylic acid and maminophenol. Acta Pharmacol. (Kbh.) 1951; 7: 376, (35, 42, 43, 121)
  • Klein E. Faulty iodine utilization by the thyroid gland. Dtsch. med. Wschr. 1959; 84: 1565, (Germ. med. Mth. 5 (1960), 98. (72, 73)
  • Klein E. Der endogene Jodhaushalt des Menschen und seine Störungen. Stuttgart 1960, (52, 66, 69)
  • Klein E. Iatrogene Störungen im Jodhaushalt. Fortschritte der Schilddrüsenforschung, K. Oberdisse, E. Klein, Stuttgart 1962; 81, (71)
  • Komrower G. M. A case of myxoedema developing during p-aminosalicylic acid therapy. Brit. med. J. 1951; II: 1193, (33, 34)
  • Koutras D. A., Alexander W. D., Buchanan W. W., Crooks J., Wayne E. J. Stable iodine metabolism in non-toxic goitre. Lancet 1960; II: 784, (83)
  • Krishnan P. S., Mehrotra R. M. L., Saxena Y. R. Liver enzymes in para-aminosalicylateinduced injury and the effect of thyroxine administration. J. Path. Bact. 1962; 83: 21, (42,47,48)
  • Krüskemper H.-L. Funktionsänderungen der Schilddrüse als Arzneimittel-Nebenwirkungen. Dtsch. med. Wschr. 1959; 84: 821, (31)
  • Kuhlbäck B., Wahlberg P. The radioactive iodine excretion test in renal failure. Scand. J. clin. Lab. Invest. 1958; 10: 11, (51)
  • Kurland G. S., Lucas J. L., Freedberg A. S. The metabolism of intravenously infused C 14 labeled cholesterol in euthyroidism and myxedema. J. Lab. clin. Med. 1961; 57: 574, (29)
  • Kurland G. S., Krotkow M. V., Freedberg A. S. Oxygen comsumption and thyroxine deiodination by human leucocytes. J. clin. Endocr. 1960; 20: 35, (22)
  • Landing B. H., Esselhorn V. M. Vide Blizzard, R. M. 1960, (18)
  • Leblond C. P., Groos J. The mechanism of the secretion of thyroid hormone. J. clin. Endocr. 1949; 9: 149, (21)
  • Lederer E., Lederer M. Chromatography, 2. ed. Amsterdam 1957, (87)
  • Lehmann J. Para-aminosalicylic acid in the treatment of tuberculosis. Lancet 1946; 250: 15, (31)
  • Lehninger A. L. Thyroxine and the swelling and contraction cycle in mitochondria. Ann. N.Y. Acad. Sci. 1960; 86: 484, (25)
  • Lein A., Dowben R. M. Uptake and binding of thyroxine and triiodothyronine by rat diaphragm in vitro. Amer. J. Physiol. 1961; 200: 1029, (24)
  • Lemarchand-Béraud T., Vannotti A. Altération du transport plasmatique des hormones thyroïdiennes en pathologie humaine. Schweiz. med. Wschr. 1963; 93: 7, (24, 68)
  • Lerman J. Iodine components of the blood. Circulating thyroglobulin in normal persons and in persons with thyroid disease 1940; 19: 555, (69)
  • Lewitus Z., Anbar M., Guttmann S. A Contribution to the Understanding of the “Trapping Mechanism” in the Thyroid Gland, R. Pitt-Rivers. Advances in Thyroid Research, Lond 1961; 235, (19)
  • Librach I. M. Antithyroid action of P.A.S. Lancet 1952; 263: 538, (33)
  • Lincoln E. M., Stone S., Hoffmann O. R. The treatment of miliary tuberculosis with promizole. Bull. Johns Hopk. Hosp. 1948; 82: 56, (33)
  • Lissitzky S., Gregoire J., Gregoire J., Limozin N. The presence and in vitro activity of free iodinated peptides in the thyroid gland of mammals and man. Gen. comp. Endocr. 1961; 1: 519, (20)
  • Macgregor A. G., Miller H., Blaney P. J., Whimster W. S. Diagnosis of thyrotoxicosis by a simple out-patient radioactive iodine technique. Brit. med. J. 1953; II: 21, (67)
  • Macgregor A. G., Somner A. R. The anti-thyroid action of para-aminosalicylic acid. Lancet 1954; 267: 931, (31, 32, 33, 34, 36, 38, 39, 41, 81, 84)
  • Mackenzie C. G., Mackenzie J. B. Effect of sulfonamides and thioureas on the thyroid gland and basal metabolism. Endocrinology 1943; 32: 185, (48)
  • Mackenzie C. G. Differentiation of the antithyroid action of thiouracil, thiourea and PABA from sulfonamides by iodide administration. Endocrinology 1947; 40: 137, (48)
  • McKenzie J. M. Delayed thyroid response to serum from thyrotoxic patients. Endocrinology 1958; 62: 865, (27)
  • McKenzie J. M. The thyroid activator of hyperthyroidism. Trans. Ass. Amer. Phycns. 1959; 72: 122, (27)
  • Madigan D. G., Griffiths L. L., Lynch M. J. G., Bruce R. A., Kay S., Brownlee G. Para-aminosalicylic acid in tuberculosis. Lancet 1950; I: 239, (31)
  • Magalotti M. F., Hummon I. F., Hirschbiel E. The effect of disease and drugs on the twenty-four hour I 131 thyroid uptake. Amer. J. Roentgenol. 1959; 81: 47, (51)
  • Maloof F., Soodak M. The inhibition of the metabolism of thiocyanate in the thyroid of the rat. Endocrinology 1959; 65: 106, (19)
  • Man E. B., Kydd D. M., Peters J. P. Butanol-extractable iodine of serum. J. clin. Invest. 1951; 30: 531, (57, 69)
  • Man E. B., Bondy P. K. Clinical significance of serum butanol-extractable iodine. J. clin. Endocr. 1957; 17: 1373, (68)
  • Mandl R. H., Block R. J. Methods for the qualitative, semiquantitative and quantitative determination of iodoamino acids and of inorganic iodide in iodoprotein digests and in human serum. Arch. Biochem. 1959; 81: 25, (95)
  • Mathiasen J. E. Juvenil atoksisk struma i Gudenådalen. Ugeskr. Læg. 1962; 124: 63, (66)
  • Mathiasen J. E. Juvenil atoksisk struma. Ugeskr. Læg. 1962; 124: 1166, (66)
  • McConahey W. M., Keating F. R., jr, Power M. H. An estimation of the renal and extrarenal clearance of radioiodide in man. J. clin. Invest. 1951; 30: 778, (59)
  • McQuillan M. T., Trikojus V. M. Purification and properties of thyroid protease. Aust. J. biol. Sci. 1953; 6: 617, (21)
  • McQuillan M. T., Stanley P. G., Trikojus V. M. A study of the action of purified thyroid protease on 131 I-labelled thyroglobulin. Aust. J. biol. Sci. 1954; 7: 319, (21)
  • Mehrotra R. M. L., Chandra S., Singh M. P., Gupta N. N. Changes in the liver of albino rats after administration of para-aminosalicylic acid. Indian J. med. Res. 1959; 47: 500, (42, 46)
  • Mehrotra R. M. L., Sarna S. Thyroid hormone and para-aminosalicylate-induced liver changes. J. Path. Bact. 1961; 82: 522, (42, 46)
  • Michailovsky N., Langer P. Gehalt einiger Nahrungsmittcl an präformiertem Rhodanid. Hoppe-Seylers Z. physiol. Chem. 1958; 312: 26, (27)
  • Mitchell R. S. The limitations of our knowledge about para-aminosalicylic acid. Amer. Rev. Tuberc. 1957; 76: 491, (31)
  • Morton M. E., Chaikoff I. L. The formation in vitro of thyroxine and diiodotyrosine by thyroid tissue with radioactive iodine as indicator. J. biol. Chem. 1943; 147: 1, (45)
  • Moudgal N. R., Srinivasan V., Sarma P. S. Studies on goitrogenic agents in food. J. Nutr. 1957; 61: 97, (115)
  • Munkner T., Clausen J. 1960, Unpublished experiments.(41, 42, 44)
  • Munkner T., Freedberg A. S. Kongressbericht vom Freiburger Symposion. Schattauer Verlag, Stuttgart 1963, (im Druck) (23, 24, 41, 42, 44, 86)
  • Myant N. B., Pochin E. E., Goldie E. A. G. The plasma iodide clearance rate of the human thyroid. Clin. Sci. 1949; 8: 109, (16)
  • Myant N. B., Pochin E. E. The thyroid clearance rate of plasma iodine as a measure of thyroid activity. Proc. roy. Soc. Med. 1949; 42: 959, (16)
  • Myhill J., Hales I. B. Salicylate action and thyroidal autonomy in hyperthyroidism. Lancet 1963; I: 802, (45)
  • Newburger R. A., Silver S., Yohalem S. B., Feitelberg S. Uptake and blood level of radioactive iodine in hyperthyroidism. New Eng. J. Med. 1955; 253: 127, (67)
  • Oberdisse K., Klein E. Fortschritte der Schilddrüsenforschung, 1. Aufl. Stuttgart 1962, (12)
  • Olsen P. Z., Tørning K. Psychological side-effects during long-term ambulatory chemotherapy with isoniazid and PAS. Acta tuberc. scand. 1959; 37: 89, (126)
  • Oscarsson P. N. Några biverkningar av aminosalyl, streptomycin och isoniazid. Svenska Läk.-Tidn. 1960; 57: 3369, (31,33)
  • Ostrovskii Yu. M. The influence of P.A.S. on endocrine glands, enzymes and the metabolism of vitamins. (In Russian). Sovr. Probl. Tuberk. 1957; 8: 11, (31)
  • Owen C. A., jr, McConahey W. M., Keating F. R., jr, Orvis A. L. Investigation of diseases of the thyroid gland by means of radioactive iodine. Fed. Proc. 1955; 14: 723, (16)
  • Owen C. A., jr, McConahey W. M. An unusual iodinated protein of the serum in Hashimoto's thyroiditis. J. clin. Endocrin. 1956; 16: 1570, (69)
  • Paley K. R., Sobel E. S., Yalow R. S. A comparison of the thyroidal plasma I 131 clearance and the plasma protein-bound I 131 tests for the diagnosis of hyperthyroidism. J. clin. Endocr. 1955; 15: 995, (16)
  • Parhon C. I., Secareanu S., Pitis M., Jancy L. Actiunea P.A.S.-ului si a derivatilor (esterii etilic si benzilic) asupra sistemului endocrin. Bul. sti. Sec. Sti. med. (Buc.) 1956; 8: 169, (42)
  • Paris J., Ford E., Lorenz N., Keating F. R., jr, Albert A. Effect of hormones on renal clearance of radioiodine in the rat. Amer. J. Physiol. 1955; 183: 163, (16)
  • Pätiälä J., Isotalo A. Experimental studies of thyroid gland reaction during treatment with para-aminosalicylic acid, dihydrostreptomycin, isoniazid and viosin. Ann. Med. exp. Fenn. 1955; 33: 25, (42, 43)
  • Pendred V. Deaf-mutism and goitre. Lancet 1896; II: 532, (20)
  • Peräsalo O., Tala P. Effect of para-aminosalicylic acid (PAS) on thyroid activity. Ann. Med. exp. Fenn. 1957; 35: 89, (42, 43)
  • Perlman I., Morton M. E., Chaikoff I. L. The selective uptake of bromine by the thyroid gland with radioactive bromine as indicator. Amer. J. Physiol. 1941; 134: 107, (18)
  • Perlmutter M., Riggs D. S. Thyroid collection of radioactive iodide and serum protein-bound iodine concentration in senescence, in hypothyroidism and in hypopituitarism. J. clin. Endocr. 1949; 9: 430, (52)
  • Perry W. F., Hughes J. S. F. The urinary excretion and thyroid uptake of iodine in renal disease. J. clin. Invest. 1952; 31: 457, (51)
  • Peters H. P., Man E. B. The relation of albumin to precipitable iodine of serum. J. clin. Invest. 1948; 27: 397, (51)
  • Pimstone B. L., Hoffenberg R., Black R. Parallel assays of thyrotrophin, long-acting thyroid stimulator and exophthalmos-producing substance in some endocrine disorders. J. clin. Endocr. 1963; 23: 336, (29)
  • Pitney W. R., Fraser T. R. The mode of action of antithyroid drugs: results with two in vitro tests. J. Endocr. 1953; 9: 224, (47)
  • Pitt-Rivers R., Hubble D., Hoather W. H. A chromatographic study of thyroidal iodine metabolism in nontoxic nodular goiter. J. clin. Endocr. 1957; 17: 1313, (15)
  • Pitt-Rivers R., Tata J. R. The Thyroid Hormones, 1. ed. Lond 1959, (12, 91)
  • Pitt-Rivers R. Advances in Thyroid Research, 1. ed. Lond 1961, (12)
  • Pitt-Rivers R., Cavalieri R. R. The free iodotyrosines of the rat thyroid gland. Biochem. J. 1963; 86: 86, (20)
  • Prout W. 21, Quoted from WHO monograph series no. 44: Endemic Goitre (14)
  • Pugh D. L., Edwards G. F., McLaren R. G., Jones E. R. Toxic psychiatric manifestations in the treatment of tuberculosis with sodium para-aminosaiicylate. Tubercle (Edinb.) 1952; 33: 369, (127)
  • Quimby E. H., Werner S. C., Schmidt C. Influence of age, sex, and season upon radioiodine uptake by the human thyroid. Proc. Soc. exp. Biol. 1950; 75: 537, (52)
  • Rall J. E., Robbins J., Edelhoch H. Iodoproteins in the thyroid. Ann. N.Y. Acad. Sci. 1960; 86: 373, (21)
  • Rauen H. M. Biochemisches Taschenbuch, 1. Aufl. Berlin 1956; 525, (131)
  • Recant L., Riggs D. S. Thyroid function in nephrosis. J. clin. Invest. 1952; 31: 789, (114)
  • Reilly W. A., Searle G. L., Scott K. G. Resin column chromatography by Dowex 50-X-4 of I 131 labeled iodoamino acids in human serum. Metabolism 1961; 10: 869, (133)
  • Reinwein D., Liebermeister H. Über den Rhodangehalt im Serum bei Erkrankungen der Schilddrüse. Klin. Wschr. 1961; 39: 130, (26)
  • Riggs D. S. Quantitative aspects of iodine metabolism in man. Pharmacol. Rev. 1952; 4: 284, (14, 16, 59, 68, 71)
  • Riska N. Dysthyreos och aminosaly!. Nord. Med. 1952; 48: 1300, (32, 33, 34)
  • Riska N. The effect of PAS on the cholesterol level in the blood. Acta tuberc. scand. 1955; 30: 134, (74)
  • Robbins J., Rall J. E., Becker D. V., Rawson R. W. The nature of the serum iodine after large doses of I 131. J. clin. Endocr. 1952; 12: 856, (69)
  • Robbins J. Thyroglobulin in serum after I 131 therapy. I. Salting out. J. biol. Chem. 1954; 208: 377, (69)
  • Robbins J., Peterman M. L., Rall J. E. Thyroglobulin in serum after I 131 therapy. II. Sedimentation in the ultracentrifuge. J. biol. Chem. 1954; 208: 387, (69)
  • Robbins J., Rall J. E., Rawson R. W. An unusual instance of thyroxine-binding by human serum gamma globulin. J. clin. Endocr. 1956; 16: 573, (69)
  • Robbins J., Rall J. E. Proteins associated with the thyroid hormones. Physiol. Rev. 1960; 40: 415, (21, 24)
  • Roche J., Michel R., Lafon M., Sadhu D. P. Sur la formation de la thyroxine et de ses précurseurs dans les iodoprotéines et les iodopeptones. Biochim. biophys. Acta (Amst.). 1949; 3: 648, (21)
  • Roche J., Deltour G.-H., Michel R., Lissitzky S. Sur la protéolyse thyroïdienne de la thyroglobuline radioactive. C.R. Soc. Biol. (Paris). 1950; 144: 1647, (21)
  • Roche J., Lissitzky S., Michel R. Sur la triiodothyronine, produit intermédiaire de la transformation de la diiodothyronine en thyroxine. C.R. Acad. Sci. (Paris). 1952; 234: 997, (15)
  • Roche J., Lissitzky S., Michel R. Sur la présence de triiodothyronine dans la thyroglobuline. C.R. Acad. Sci. (Paris). 1952; 234: 1228, (15)
  • Roche J., Lissitzky S., Michel R. Charactérisation des iodohistidines dans les protéines iodées (thyroglobuline et iodoglobine). Biochim. biophys. Acta (Amst.) 1952; 8: 339, (15)
  • Roche J., Michel R., Michel O., Lissitzky S. Sur la déshalogénation enzymatique des iodoty-rosines par le corps thyroïde et sur son role physiologique. Biochem. biophys. Acta. 1952; 9: 161, (22)
  • Roche J., Michel O., Michel R., Gorbman A., Lissitzky S. Sur la deshalogénation enzymatique des iodotyrosines par le corps thyroïde et sur son role physiologique. II. Biochim. biophys. Acta (Amst.). 1953; 12: 570, (22)
  • Roche J., Lissitzky S., Michel R. Chromatographic Analysis of Radioactive Iodine Compounds from the Thyroid Gland and Body Fluids. Methods of Biochemical Analysis, ed. 1, D. Glick, , NY 1954; vol. 1: 243, (94)
  • Roche J., Michel R., Wolf W. Présence probable de la 3:3′: 5′-triiodothyronine dans la thyroglobuline. C.R. Acad. Sci. (Paris). 1955; 240: 251, (14)
  • Roche J., Michel R., Wolf W., Nunez J. Sur la présence dans la thyroglobuline de la 3:3′-diiodothyronine, nouvelle hormone thyroïdienne. C.R. Acad. Sci. (Paris). 1955; 240: 921, (14)
  • Roche J., Michel R., Nunez J., Wolf W. Sur la présence dans le plasma de la 3 :3′-diiodothyronine, nouvelle hormone thyroïdienne. C.R. Soc. Biol. (Paris). 1955; 149: 884, (15)
  • Roche J., Michel R., Nunez J. Sur la présence de la 3:3′:5′-triiodothyronine dans le sang de rat. C.R. Soc. Biol. (Paris). 1956; 150: 20, (15)
  • Roche M., de Venanzi F., Vera J., Coll E., Spinetti-Berti M., Mendes-Martinez J., Gerardi A., Forero J. Endemic goiter in Venezuela studied with I 131. J. clin. Endocr. 1957; 17: 99, (17, 66)
  • Ronin M. Étude de la fonction thyroïdienne au cours de la nephrose lipoidique. These, Lyon 1958, (114)
  • Rosenberg I. N. The antithyroid activity of some compounds that inhibit peroxidase. Science 1952; 116: 503, (39,42,46,47)
  • Rosenman R. H., Byers S. O., Friedman M. The mechanism responsible for the altered blood cholesterol content in deranged thyroid states. J. clin. Endocr. 1952; 12: 1287, (29)
  • Rosenquist K. Om Strumaproblemet. (Disp.). København 1943, (66)
  • Rowlands E. N., Edwards D. A. W., Honour A. J. Study of the effect of perchlorate and thio-cyanate on salivary iodide. Clin. Sci. 1953; 12: 399, (39)
  • Rupp J. J., Chavarria-Bonizue C., Paschkis K. E. Goitrous cretinism in two sisters. Metabolism 1960; 9: 427, (116)
  • Salerno G. Ricerche istologiche ed istochimiche sull' azione antitiroidea dell'acido para-aminosalicilico. Arch. Tisiol. 1955; 10: 944, (42, 47)
  • Samuel P. Effect of neomyxin, para-aminosalicylic-acid and other antibacterial drugs on serum cholesterol level of man. Proc. Soc. exp. Biol. 1959; 102: 194, (74)
  • Scazziga B. R., Barbieri L. L., Béraud T. La fonction thyroïdienne chez le vieillard. Schweiz. med. Wschr. 1955; 85: 393, (52)
  • Scazziga B. R., Barbieri L. L., Béraud T. La fonction thyroïdienne dans les affections du parenchyme hépatique. Schweiz. med. Wschr. 1955; 85: 471, (51)
  • Scazziga B. R., Béraud T., Vannotti A. Étude de métabolisme hépatobiliaire de l'hormone thyroïdienne chez l'homme à l'aide de l'iode 131. Schweiz. med. Wschr. 1955; 85: 1019, (51)
  • Scazziga B. R., Béraud T., Vanotti A. La fonction thyroïdienne dans l'ictere par obstruction. Schweiz. med. Wschr. 1956; 86: 875, (51)
  • Schaich W. Die Nebenwirkungen der Tuberkulostatika. Ergebn. ges. Tuberk.- u. Lung.-Forsch. 1956; 13: 109, (31)
  • Schultz A. L., Sandhaus S., Demorest H. L., Zieve L. Clinical value of the plasma butanol-extractable (thyroxine) I 131 in the diagnosis of hyperthyroidism and myxedema. J. clin. Endocr. 1954; 14: 1062, (69)
  • Scott K. G., Reilly W. A. Use of anionic exchange resin for the determination of protein-bound I 131 in human plasma. Metabolism 1954; 3: 506, (54)
  • Schwarz F., der Kinderen P. J., Houstra-Lanz M. Exophthalmos-producing activity in the serum and in the pituitary of patients with Cushing's syndrome and acromegaly. J. clin. Endocr. 1962; 22: 718, (29)
  • Schwarz F. Personal communication. 1963, (29)
  • Seinfeld E., Starr P. Studies of thyroid function in patients treated with para-aminosalicylic acid and isoniazid. Amer. Rev. resp. Dis. 1959; 80: 845, (36, 40, 82)
  • Silver S., Yohalem S. B., Newburger R. A. Pitfalls in diagnostic use of radioactive iodine. J. Amer. med. Ass. 1955; 159: 1, (71, 72)
  • Silver S. Blood Plasma Levels of Radioactive Iodine-131 in the Diagnosis of Hyperthyroidism. Advances in Clinical Chemistry, 1. ed, H. Sobotka, C. P. Stewart, , NY 1958; vol. 1: 111, (71,72)
  • Simpson D. G., Walker J. H. Hypersensitivity to para-aminosalicylic acid. Amer. J. Med. 1960; 29: 297, (31)
  • Slingerland D. W. The influence of various factors on the uptake of iodine by the thyroid. J. clin. Endocr. 1955; 15: 131, (17)
  • Smelser G. K. Experimental studies on exophthalmos. Trans. Amer. Acad. Ophthal. Otolaryng. 1962; 66: 20, (29)
  • Smith I. Chromatographic and electrophoretic techniques, 2. ed. Lond 1960; vol. 1, (87)
  • Stanbury J. B., Hedge A. N. A study of a family of goitrous cretins. J. clin. Endocr. 1950; 10: 1471, (20)
  • Stanbury J. B., Brownell G. L., Riggs D. S., Perinetti H., Itoiz J., del Castillo E. B. Endemic Goiter. The Adaption of Man to Iodine Deficiency. 1. ed. Cambridge, Mass 1954, (17, 26, 38, 66)
  • Stanbury J. B., Mejer J. W. A., Kassenaar A. A. H. The metabolism of iodotyrosines. II. The metabolism of mono- and di-iodotyrosine in certain patients with familial goiter. J. clin. Endocr. 1956; 16: 848, (116)
  • Stanbury J. B. Familial Goiter. The Metabolic Basis of Inherited Disease, 1. ed., J. B. Stanbury, J. B. Wyngaarden, D. S. Frederichsen, , NY 1960, (13, 22, 23)
  • Stanbury J. B., Chapman E. M. Congenital hypothyroidism with goitre. Absence of an iodide-concentrating mechanism. Lancet 1960; I: 1162, (18)
  • Stanbury J. B., Riccabona G., Janssen M.-A. Lodotyrosyl coupling defect in congenital hypothyroidism with goitre. Lancet 1963; I: 917, (22)
  • Stanley M. M. The direct estimation of the rate of thyroid hormone formation in man. The effect of the iodide ion on thyroid iodine utilization. J. clin. Endocr. 1949; 9: 941, (17)
  • Strange B. Radioaktivt jod ved diagnosen af sygdomme i glandula thyreoidea. Disp., Odense 1959, (52, 57, 63, 64, 65)
  • Studer H., Wyss F. Der TSH-Reservetest mit Carbimazol. Schweiz. med. Wschr. 1961; 91: 1536, (27)
  • Studer H. Eine Methode zum Nachweis der hypophysären TSH-Reserve. Helv. med. Acta. 1962; 29: 275, (27)
  • Sutherland D. A. The antithyroid effect of para-aminosalicylic acid. Trans. XII Conf. Chemotherapy of Tuberc.. 1953; 314, (36, 37, 82)
  • Sørensen P. H. Jodstofskifte og thyroideafunktion hos kvæg og svin. København 1958, (66) Disp
  • Sørensen P. H. Studies of thyroid function in cattle and pigs. Use of radioisotopes in animal biology and the medical sciences, 1. ed. Academic Press, Lond, NY 1962; vol. 1: 455, (66)
  • Talmas V., Dossin F., Ernould H. J. Action goitrigene du P.A.S. Ann. Endocr. (Paris). 1959; 19: 884, (Rev. méd. Liège. 13 (1958), 418. (33, 35)
  • Tanaka S., Starr P. Excessive circulating thyroxine in euthyroid, nonpregnant women with elevated thyroxine-binding serum globulin. Metabolism 1959; 8: 441, (24)
  • Tanaka S., Starr P. An euthyroid man without thyroxine-binding globulin. J. clin. Endocr. 1959; 19: 485, (24)
  • Tandhanand S., Buri R. Hyperthyroidism developing during P.A.S. Therapy. Brit. med. J. 1956; II: 281, (33, 34)
  • Tapley D. F., Cooper C. The effect of thyroxine and related compounds on oxidative phosphorylation. J. biol. Chem. 1956; 222: 341, (25)
  • Tata J. R. Transport of thyroid hormones. Brit. med. Bull. 1960; 16: 142, (23)
  • Tata J. R. Interaction between thyroid hormones and extra- and intracellular proteins. Bull. Soc. Chim. biol. (Paris). 1960; 42: 1171, (23, 24)
  • Tata J. R. Is there a relationship between the metabolism of thyroid hormones and their action?. Mem. Soc. Endocr. 1961; 11: 90, (24)
  • Tata J. R., Ernster L., Lindberg O., Arrhenius E., Pedersen S., Hedman R. The action of thyroid hormones at the cell level. Biochem. J. 1963; 86: 408, (25)
  • Taurog A., Potter G. D., Chaikoff I. L. Conversion of inorganic I 131 to organic I 131 by cell-free preparations of thyroid tissue. J. biol. Chem. 1955; 213: 119, (69)
  • Tengroth B. Endocrine exophthalmos. (Disp.). Acta ophthalm. (Kbh.) 1961, Suppl. 65, (29)
  • Terpstra J. De schildklier functie bij endemische Krop. Diss., Leiden 1956, (66)
  • Terpstra J., Querido A. Endemic goitre in the Netherlands. Acta endocr. (Kbh.). 1959; 31: 433, (66)
  • Thorén A. The influence of iodide and iodized compounds on the PBI and the 131 I tracer test with special reference to various biologic states. Acta endocr. (Kbh.). 1960; 35: 351, (51)
  • Tong W., Taurog A., Chaikoff I. L. Non-thyroglobulin iodine of the thyroid gland. I. Free thyroxine and diiodotyrosine. J. biol. Chem. 1951; 191: 665, (21)
  • Torikai T., Kumaoka S. The effect of para-aminosalicylic acid on hyperthyroidism. Lancet 1956; 270: 84, (44)
  • Toro-Goyco E., Cancic M. Human lipoproteins: role in transport of thyroid hormones. Science 1963; 139: 761, Tracerlog no. 66, Tracerlab Inc., 1955. (52) (23)
  • Trotter W. R. The association of deafness with thyroid dysfunction. Brit. med. Bull. 1960; 16: 92, (29)
  • Tygstrup N., Winkler K., Warburg E. Effect of p-aminosalicylic acid on serum-cholesterol. Lancet 1959; I: 503, (74)
  • Tygstrup N., Winkler K., Jørgensen K. Behandling af hyperkolesterolæmi med paraaminosalicylsyre. Ugeskr. Læg. 1961; 123: 255, (74)
  • Tørning K. Ambulant kemoterapi af lungetuberkulose. Nord. Med. 1957; 58: 1371, (33)
  • Tørning K., Jensen K. A., Kjær I. Clinical studies on tebamin. Acta tuberc. scand. 1958; 35: 87, (108)
  • van Arsdel P. P., jr, Williams R. H. Effect of propylthiouracil on degradation of I 131 labeled thyroxine and triiodothyronine. Amer. J. Physiol. 1956; 186: 440, (26)
  • Vannotti A. Étude de la fonction thyroïdienne avec l'iode radioactif, 1. ed. Basel 1957, (66)
  • Vannotti A., Béraud T., Dorta T. Distribution des composés iodés plasmatiques dans diverses maladies thyroïdiennes, R. Pitt-Rivers. Advances in Thyroid Research, Lond 1961; 434, (69)
  • Vidal J., Plane J. Réactions thyroïdiennes provoquées par l'acide para-amino-salicylique. Rev. Tuberc. (Paris). 1955; 19: 265, (33, 34)
  • Virtanen A. O. Über die Chemie der Brassica-Faktoren, ihre Wirkung auf die Funktion der Schilddrüse und ihr Übergehen in die Milch. Experientia (Basel). 1961; 17: 241, (27)
  • von Fellenberg T. Kropf und Trinkwasser in der Schweiz. Mitt. Lebensmitt. Hyg. 1933; 24: 123, (66)
  • Vunder P. A., Lapshina V. F. The goitrogenic effect of P.A.S. (In Russian). Probl. Endokr. Gormonoter. 1956; 2: 76, fasc. no. 4 (42, 43)
  • Way E. L., Peng C.-T., Allawaka N., Daniels T. C. The metabolism of p-aminosalicylic acid (PAS) in man. J. Amer. pharm. Ass. 1955; 44: 65, (94, 104)
  • Wayne E. J. The diagnosis of thyrotoxicosis. Brit. med. J. 1954; I: 411, (67)
  • Wellby M. L., Hetzel B. S. Demonstration of iodotyrosines in human plasma in response to thyroid stimulation. Nature (Lond.). 1962; 193: 752, (15)
  • Werner S. C., Spooner M. A new and simple test for hyperthyroidism employing 1-triiodothyronine and the twenty-four-hour I-131 uptake method. Bull. N.Y. Acad. Med. 1955; 31: 137, (45)
  • Werner S. C., Block R. J. Discrepancy between the distribution of iodine in human serum when estimated by iodine-131 and iodine-127. Nature (Lond.). 1959; 183: 406, (15)
  • Werner S. C., Radichevich I. Presence of iodine-127 iodotyrosines in extracts of normal human serum. Nature (Lond.). 1963; 197: 877, (15)
  • Werner S. C. The Thyroid, 2. ed. , NY 1962, (14, 29)
  • Wilansky D. L., Newsham L. G. S., Hoffman M. M. The influence of senescence on thyroid function: functional changes evaluated with I 131. Endocrinology 1957; 61: 327, (52)
  • Wilkinson J. H. Colloquia on Endocrinology (CIBA Foundation). Lond 1957; vol. 10: 228, (110)
  • Williams R. H. Textbook of Endocrinology, 3. ed. Wash 1962, (14)
  • Wolff J., Chaikoff I. L., Goldberg R. C., Meier J. R. The temporary nature of the inhibitory action of excess iodide on organic iodine synthesis in the normal thyroid. Endocrinology 1949; 45: 504, (17)
  • Wolff J., Maurey J. R. Thyroidal iodide transport. IV. The role of ion size. Biochim. biophys. Acta (Amst.). 1963; 69: 58, (19)
  • Wong T., Hogness J. R., Williams R. H. Effects of p-aminosalicylic acid on thyroid and adrenal. Proc. Soc. exp. Biol. 1953; 82: 598, (42, 46)
  • Wood J. L., Kingsland N. Labeled sulfur uptake by thyroids of rats with low plasma thiocyanate levels. J. biol. Chem. 1950; 185: 833, (18)
  • World Health Organization. Endemic Goitre, Geneva 1960, Monograph Series no. 44 (14, 66)
  • Wynn J., Fabrikant I., Deiss W. P. A method for extraction and chromatographic separation of plasma iodoamino acids. Arch. Biochem. 1959; 84: 106, (133)
  • Yagi Y., Michel R., Roche J. Sur le métabolisme des bromures radioactifs (82 Br). Bull. Soc. Chim. biol. (Paris). 1953; 35: 289, (18)
  • Zumstein P. Des effets secondaires de l'acide para-aminosalicylique (PAS). Praxis 1956; 45: 48, (31)

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.